Document is current
Any future updates will be listed below
-
Authors
Cho, Soo-Kyung
Kim, Hyoungyoung
Lee, Jiyoung
Nam, Eunwoo
Lee, Seunghun
Choi, Yun Young
Sung, Yoon-Kyoung
-
Funding
Funding for this research was provided by:
Pfizer Pharmaceuticals Korea
- License Information
-
More Information
Article History
Received: 21 September 2020
Accepted: 24 June 2021
First Online: 2 July 2021
Declarations
:
: The study protocol was approved by the Institutional Review Board (IRB) of our hospital (IRB file No. HYUN 2015-08-020) and registered in the US database (no. NCT02602704). Reporting of severe adverse events to the IRB was mandatory. Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: YKS has received research grants from Bristol-Myers Squibb, Eisai, Pfizer, and JW Pharmaceutical. SKC, HK, JL, EN, SL, and YYC have nothing to declare. All authors declare no conflict of interest about this work.
